References
Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med 2006, 145: 901–12.
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348: 383–93.
Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 2001, 86: 965–71.
Grundy SM, Cleeman JI, Merz CN, et al; Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004, 44: 720–32.
Dworkin LD. Controversial treatment of Atherosclerotic Renal Vascular Disease: the cardiovascular outcomes in renal atherosclerotic lesions trial. Hypertension 2006, 48: 350–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maranghi, M., Pugliese, F., Cianci, R. et al. Atherosclerosis renal artery stenosis and in-stent restenosis in adiabetic patient: Targeting on diabetic dyslipidemia is akey intervention. J Endocrinol Invest 33, 284–285 (2010). https://doi.org/10.1007/BF03345794
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345794